PMID: 799306Jan 1, 1976Paper

Clinical problems with HLA sensitization

Progress in Clinical and Biological Research
H F Polesky

Abstract

There is little question that Frozen-Thawed-Deglycerolized Red Cells (Human) has the least amount of HLA antigen found in any red cell component. Units prepared by any of the several availables methods are indicated for patients with repetitive nonhemolytic febrile reactions, probably should be used in patients waiting for reanl allografts and in immunodeficient patients in whom there is a risk of GVH disease. Still unresolved are questions on the minimal dose of HLA needed to sensitize a recipient, the role of the debris and viable cells and whether transfusion with a small dose of HLA antigen has a beneficial effect on the survival of renal allografts.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.